No Slide Title

Download Report

Transcript No Slide Title

Bone Loss In The Elderly
Liliana Oakes, M.D.
Assistant Professor –Geriatric Division
David V. Espino, M.D.
Professor and Vice Chair, Dept. of Family. & Comm. Medicine
University of Texas Health Science Center, San Antonio
Osteoporosis
•
•
•
•
Epidemiology
Risk Factors
Diagnosis
Treatment
Osteoporosis: Epidemiological
Classification
• Type I (Postmenopausal)
– Women, Trabecular Bone, Fx Vertebra, Distal Radius
• Type II (Senile)
– Men/Women, Cortical & Trabecular Bone, Fx Hip,
Vertebra, Humerus Tibia, Pelvis
• Type III (Secondary)
– Men/Women, Cortical & Trabecular Bone, Fx of
Vertebra
Secondary Osteoporosis
• Nutritional
–
–
–
–
Lo Ca Intake
Vit D Deficiency
Protein Malnutrition
Alcoholism
• Neoplastic Diseases
– Multiple Myeloma
– Lymphoma
– Monocytic Leukemia
• Endocrine
–
–
–
–
Cushing’s
Hyperthyroidism
Hyperparathyroidism
Hypogonadism
• Systemic
– Hepatic Disease
– Renal Disease
– Rheumatoid Arthritis
Drug Induced Secondary Osteoporosis
•
•
•
•
Corticosteroids
Aluminum Containing Antacids
Heparin
Anticonvulsants
– (Dilantin, Phenobarb, Primidone)
• Phenothiazines
• Furosemide
• Thyroid Hormone
– (In Excessive Doses)
Bone Quality
• FX Pathogenesis
Involves More Than
Bone Mass
– Bone Density
– Structural Arrangement
– Adequacy of
Mineralization
– Presence of
Microdamage
Osteopenia Scope
• Year 2020
– 14 million persons
with osteoporosis
– 61 million with low
bone mass
• Second Only To CVD
according to WHO
U.S.Women in WHO Categories
100
90
80
70
60
50
40
30
20
10
0
Age 25
Severe OP
Osteoporosis
Osteopenia
Normal
Age 50
Age 65
Age 80
Osteoporosis
•
•
•
•
Risk Factors
Epidemiology
Diagnosis
Treatment
B. Spears
• 82 yo White Female
• HTN, CAD, Hearing
Loss
• History of Falls
• Low Back Pain
• Smoker
Risk Factors
• What information from Mrs. Spears history
will suggest to you she is at risk for
osteoporosis?
Osteoporosis Risk Factors
Non Modifiable
•
•
•
•
•
Age
Race
Gender
Family History
Early Menopause
/Oophorectomy
Osteoporosis Risk Factors
Modifiable
•
•
•
•
•
•
Weight
Physical Activity
Ca/Vit D Intake
Cigarette Smoking
Glucocorticoids
Sex Hormone
Insufficiency
Osteoporosis
• Introduction
• Epidemiology &
Risk Factors
• Diagnosis
• Treatment
B. Spears
• 82 yo White Female
• HTN, CAD, Hearing
Loss
• History of Falls
• Low Back Pain
• Smoker
History
•
•
•
•
•
•
•
Hx of Prior Fractures
Falls Hx
Neurological D-Z Hx
Hx of Muscular Weakness
Nutritional Hx
Medication Hx
Functional Hx
Nutritional History
• Deficiency States
–
–
–
–
–
–
Calcium
Vitamin D
Vitamin C
Zinc?
Manganese?
Boron?
• Excess Intake
–
–
–
–
–
–
Insoluble Fiber
Animal Protein
Phosphate
Alcohol
Smoking
Vitamins D or A
Physical Examination
•
•
•
•
•
Orthostatics
Gait & Mobility
Height
Kyphosis?
Clinical Features of
– Hypercortisolism
– Hyperthyroid, Hypogonadism
Laboratory Evaluation
• CBC, TFT’s
• Chem Profile to include:
– Albumin (Nutritional?)
– Renal/Liver function
– Calcium (Elevated in
Hyperparathyroid)
– Phosphate (Low in
Osteomalacia)
– Alk Phos (Elevated in
Osteomalacia)
• 24 Hour Urine for Calcium &
Creatinine
• ESR (with back pain)
• DEXA
WHO Definition
• Osteopenia
– 1-2.5 sd Below Mean
• Osteoporosis
– >2.5 sd Below Mean
Dual Energy X-Ray Absorptiometry
[DEXA]
•
Z-score
– the number of standard
deviations from the agematched average value
of healthy women,
•
T-score
– the number of standard
deviations from the value
at peak bone density of a
young (25-30 year old)
Caucasian woman.
– Alone Does Not Predict
FX or Guide Therapy
Indications for DEXA in Men
• Age≥70
• Low Trauma FX
• Prevalent Vertebral
Deformities
• Radiographic
Osteopenia
• Conditions Associated
with Bone Loss
Indications for Spinal
Radiographs
• Acute or Persistent
Bone Pain
• “Normal” DEXA
• Hx of Malignancy
• Kyphosis/Scoliosis
• Significant Height
Loss (≥5 cm)
Osteoporosis
• Introduction
• Epidemiology &
Risk Factors
• Diagnosis
• Treatment
B. Spears
• 82 yo White Female
• HTN, CAD, Hearing
Loss
• History of Falls
• Low Back Pain
• Smoker
Treatment Plan
• You are discussing a treatment plan with
Mrs. Spears.
• What recommendations you will give to her
to treat her osteoporosis.
Exercise
• Weight-Bearing
Exercise
• Vigorous Training vs.
Exercise
Vitamin D
• Most MVI’s contain
400 U
• Dietary Sources
– Sardines,Salmon,
Butter,Organ Meats,
Egg Yolks, Fortified
Foods
• Vitamin D Def.
– 800 U
– Monitor Ca Levels
Calcium
• 1.5 Grams Per Day
• Choice of Product
Based on Cost and
Convenience
• Lactose Intolerance
– Avoid Calcium Lactate
Calcium Intake
• Best Absorbed With Meals
• Evening Meal Best
• Decrease Caffeine and Sodium
Intake
• Contraindicated
– Hypercalcuria &
Nephrolithiasis
– Sarcoidosis
– Hyperparathyroidism
– Maligancies assoc. with
Hypercalcemia
Dietary Calcium
• Repka’s Rule of 300s
– 8 oz. of Yogurt =300
mg Ca
– 8 oz. Of OJ
= 300 mg Ca
– 8 oz. of Milk
=300 mg Ca
C. E. Estrogen & Progesterone
• Not Include Estrogen
Alone
• HERS & WHI
Selective Estrogen Receptor
Modulators (SERM’s)
• Tamoxifen
• Raloxifene
– Reduces vertebral fractures
– No effect on nonvertebral Fx’s
– Increases Thromboembolism,
Hot Flashes
– No increase in Uterine CA
– Positive Lipid and Breast CA
benefits
– Perimenopausal or Early
Menopausal (55-65) Time
• Vertebral Fxs common, Hip
are not
Calcitonin
• Calcitonin-Salmon
• Calcitonin-Intranasal
Biphosphonates
• Etidronate (Didronel®)
– Osteomalacia in Pts. With
Osteoporosis or Pagets
• Alendronate (Fosamax®)
• Risedronate (Actonel®)
• Pamidronate (Aredia®)
– Ibandronate ( in trial)
Experimental Agents
• Fluoride
– Ca Resorption
• PTH. (Forteo®)
Regulates bone
metabolism
•
•
•
•
Growth Hormone
HCTZ
Potassium Bicarbonate
Vitamin D Metabolites
Vertebral Compression Fx Treatment
• Short Term Bedrest
• Weight Bearing
Movement ASAP
• NSAID’s PRN
• Calcitonin
– 2 Weeks
• Rehab
Summary
• Osteoporosis Is Second Only To CVD in
Terms Of Morbidity
• Early Diagnosis Is Critical
• Therapies Very Effective
• Remember Elder Men
Questions?